MDxHealth SA (MDXH)
NASDAQ: MDXH · IEX Real-Time Price · USD
2.590
+0.130 (5.28%)
At close: Mar 28, 2024, 4:00 PM
2.580
-0.010 (-0.39%)
After-hours: Mar 28, 2024, 6:01 PM EDT

MDxHealth Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Revenue
70.1937.0522.2418.4611.79
Revenue Growth (YoY)
89.43%66.62%20.47%56.64%-
Cost of Revenue
26.2617.8411.6810.4211.76
Gross Profit
43.9319.2210.568.040.03
Selling, General & Admin
59.9349.0131.8930.7433.01
Research & Development
6.385.56.674.549
Other Operating Expenses
4.962.61-1.16-0.121.2
Operating Expenses
71.2657.1237.4135.1743.2
Operating Income
-27.33-37.9-26.84-27.12-43.17
Interest Expense / Income
15.776.142.161.540.52
Other Expense / Income
-----0.01
Pretax Income
-43.1-44.04-29-28.66-43.68
Income Tax
0000-0.58
Net Income
-43.1-44.04-29-28.66-43.1
Shares Outstanding (Basic)
27161616-
Shares Change
73.36%----
EPS (Basic)
-16.60-27.80-24.00-34.00-69.00
EPS (Diluted)
-16.60-27.80-24.00-34.00-69.00
Free Cash Flow
-24.24-36.91-23.44-20.78-22.36
Free Cash Flow Per Share
-8.97-23.66-15.03-13.32-
Gross Margin
62.58%51.87%47.50%43.58%0.25%
Operating Margin
-38.93%-102.28%-120.69%-146.93%-366.30%
Profit Margin
-61.40%-118.86%-130.41%-155.27%-365.72%
Free Cash Flow Margin
-34.54%-99.60%-105.42%-112.57%-189.75%
EBITDA
-20.47-32.99-23.81-23.79-39.74
EBITDA Margin
-29.16%-89.03%-107.04%-128.88%-337.20%
Depreciation & Amortization
6.864.913.043.333.42
EBIT
-27.33-37.9-26.84-27.12-43.16
EBIT Margin
-38.93%-102.28%-120.69%-146.93%-366.22%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).